Loading…
Gian Lifecare (BSE 542918)₹4.27+2.89%Healthcare Service Provider
In the Dec 2025 quarter (consolidated), Gian Lifecare reported sales of ₹1.11 Cr, down 29.7% from Dec 2024, and net profit of ₹0.09 Cr, down 73.5% year on year. For the year to Mar 2025, sales were ₹5.92 Cr and net profit −₹0.03 Cr.
Company filings, consolidated accounts; latest reported quarter Dec 2025
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.54 | 2.42 | 2.29 | 3.78 | 4.59 | 1.97 | 1.94 | 1.58 | 1.10 | 0.86 | 0.65 | 1.11 |
| Expenses | 2.30 | 1.91 | 1.96 | 1.58 | 1.54 | 1.75 | 1.73 | 1.11 | 1.11 | 0.73 | 1.06 | 0.86 |
| Operating Profit | −0.75 | 0.50 | 0.32 | 2.19 | 3.04 | 0.21 | 0.20 | 0.46 | 0.00 | 0.12 | −0.40 | 0.24 |
| OPM % | −49.1% | 20.9% | 14.3% | 58.0% | 66.2% | 11.0% | 10.7% | 29.5% | −0.9% | 14.9% | −62.2% | 22.2% |
| Other Income | 0.17 | 0.13 | 0.14 | 0.18 | 0.17 | 0.18 | 0.16 | 0.15 | −0.23 | 0.14 | 0.08 | 0.08 |
| Interest | 0.10 | 0.11 | 0.10 | 0.13 | 0.09 | 0.13 | 0.11 | 0.11 | 0.12 | 0.08 | 0.11 | 0.14 |
| Depreciation | 0.13 | 0.14 | 0.14 | 0.17 | 0.12 | 0.13 | 0.13 | 0.13 | 0.28 | 0.12 | 0.12 | 0.12 |
| Profit before tax | −0.82 | 0.41 | 0.25 | 2.10 | 3.03 | 0.16 | 0.15 | 0.40 | −0.66 | 0.09 | −0.56 | 0.09 |
| Tax % | 17.3% | 35.1% | 16.7% | 25.4% | 29.5% | 40.1% | 14.3% | 10.3% | −7.7% | 37.6% | −7.3% | −37.5% |
| Net Profit | −0.94 | 0.25 | 0.19 | 1.54 | 2.12 | 0.08 | 0.11 | 0.34 | −0.59 | 0.04 | −0.50 | 0.09 |
| EPS (Rs) | −0.91 | 0.24 | 0.18 | 1.49 | 2.05 | 0.08 | 0.11 | 0.33 | −0.57 | 0.04 | −0.48 | 0.09 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| Sales | 15.41 | 11.39 | 12.75 | 5.92 | 3.72 |
| Expenses | 9.36 | 9.53 | 6.61 | 4.96 | 3.76 |
| Operating Profit | 6.04 | 1.84 | 6.14 | 0.95 | −0.04 |
| OPM % | 39.1% | 16.2% | 48.0% | 16.1% | −1.1% |
| Other Income | 0.50 | 0.68 | 0.66 | 0.25 | 0.07 |
| Interest | 0.38 | 0.44 | 0.53 | 0.54 | 0.45 |
| Depreciation | 0.34 | 0.51 | 0.54 | 0.64 | 0.64 |
| Profit before tax | 5.86 | 1.60 | 5.76 | 0.05 | −1.04 |
| Tax % | 25.4% | 33.4% | 27.7% | 200.0% | — |
| Net Profit | 4.36 | 1.05 | 4.14 | −0.03 | −0.96 |
| EPS (Rs) | 4.22 | 1.01 | 3.99 | −0.03 | −0.92 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 10.32 | 10.32 | 10.31 | 10.32 |
| Reserves | 3.70 | 4.79 | 8.95 | 8.90 |
| Borrowings | 2.04 | 4.59 | 4.90 | 5.86 |
| Other Liabilities | 7.03 | 8.54 | 8.46 | 10.86 |
| Total Liabilities | 23.09 | 28.24 | 32.62 | 35.94 |
| Fixed Assets | 3.51 | 4.61 | 5.06 | 4.44 |
| CWIP | 0.13 | 0.15 | 0.15 | 0.15 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 19.45 | 23.48 | 27.41 | 31.35 |
| Inventories | 1.48 | 0.87 | 0.87 | 0.61 |
| Trade receivables | 1.77 | 3.24 | 4.80 | 6.08 |
| Cash & equivalents | 4.84 | 5.76 | 5.98 | 6.95 |
| Total Assets | 23.09 | 28.24 | 32.62 | 35.94 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Cash from operating activity | 5.80 | 2.23 | 0.71 | 0.28 |
| Cash from investing activity | −4.11 | −0.93 | −0.31 | 0.24 |
| Cash from financing activity | 0.68 | −0.38 | −0.17 | 0.46 |
| Net cash flow | 2.33 | 0.90 | 0.21 | 0.96 |
| Capex | 0.97 | 1.64 | 0.99 | 0.02 |
| Free cash flow | 4.84 | 0.60 | −0.27 | 0.27 |
| CFO / OP % | 107.0% | 120.9% | 12.0% | 31.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor days | 41 | 103 | 136 | 373 |
| Cash conversion cycle | 43 | 105 | 138 | 375 |
| Working capital days | −32 | −162 | −81 | −76 |
| ROCE % | — | 11.4% | 28.7% | 2.4% |
For the Dec 2025 quarter, Gian Lifecare reported sales of ₹1.11 Cr, down 29.7% year on year and net profit of ₹0.09 Cr, down 73.5% year on year. The operating margin was 22.2%.
Gian Lifecare's sales for the year to Mar 2025 were ₹5.92 Cr; over the last twelve months they were ₹3.72 Cr.
Net profit for the year to Mar 2025 was −₹0.03 Cr, and −₹0.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.92.
Gian Lifecare reported borrowings of ₹5.86 Cr at Mar 2025, against cash and equivalents of ₹6.95 Cr.
Cash from operations was ₹0.28 Cr in the year to Mar 2025; after capital spending, free cash flow was ₹0.27 Cr.